BindingDB logo
myBDB logout

Patent code US9181253

Compile Data Set for Download or QSAR
Found 52 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)		LigandTarget/Host
Links		Ligand
Links		Trg + Lig
Links		Ki
nM		ΔG°
kJ/mole		IC50
nM		Kd
nM		EC50/IC50
nM		koff
s-1		kon
M-1s-1		pHTemp
°C
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191046
PNG
(US9181253, 109)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CCC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C15H18ClN5O2/c16-14-19-12(18-7-2-1-3-7)10-13(20-14)21(6-17-10)15-4-8(15)11(23)9(22)5-15/h6-9,11,22-23H,1-5H2,(H,18,19,20)/t8-,9-,11+,15-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 5.90 -47.0n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191068
PNG
(US9181253, 115)
Show SMILES CCNc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C13H16ClN5O2/c1-2-15-10-8-11(18-12(14)17-10)19(5-16-8)13-3-6(13)9(21)7(20)4-13/h5-7,9,20-21H,2-4H2,1H3,(H,15,17,18)/t6-,7-,9+,13-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 6.60 -46.7n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191057
PNG
(US9181253, 119)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NCC3CC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C15H18ClN5O2/c16-14-19-12(17-5-7-1-2-7)10-13(20-14)21(6-18-10)15-3-8(15)11(23)9(22)4-15/h6-9,11,22-23H,1-5H2,(H,17,19,20)/t8-,9-,11+,15-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 8.90 -46.0n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191061
PNG
(US9181253, 123)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NCc3ccccc3OCCF)nc(Cl)nc12 |r|
Show InChI InChI=1S/C20H21ClFN5O3/c21-19-25-17(23-9-11-3-1-2-4-14(11)30-6-5-22)15-18(26-19)27(10-24-15)20-7-12(20)16(29)13(28)8-20/h1-4,10,12-13,16,28-29H,5-9H2,(H,23,25,26)/t12-,13-,16+,20-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 10.3 -45.6n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191055
PNG
(US9181253, 117)
Show SMILES CC(C)Nc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C14H18ClN5O2/c1-6(2)17-11-9-12(19-13(15)18-11)20(5-16-9)14-3-7(14)10(22)8(21)4-14/h5-8,10,21-22H,3-4H2,1-2H3,(H,17,18,19)/t7-,8-,10+,14-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 12 -45.2n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191045
PNG
(US9181253, 108)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C14H16ClN5O2/c15-13-18-11(17-6-1-2-6)9-12(19-13)20(5-16-9)14-3-7(14)10(22)8(21)4-14/h5-8,10,21-22H,1-4H2,(H,17,18,19)/t7-,8-,10+,14-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 12.1 -45.2n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191062
PNG
(US9181253, 124)
Show SMILES CCOc1ccccc1CNc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C20H22ClN5O3/c1-2-29-14-6-4-3-5-11(14)9-22-17-15-18(25-19(21)24-17)26(10-23-15)20-7-12(20)16(28)13(27)8-20/h3-6,10,12-13,16,27-28H,2,7-9H2,1H3,(H,22,24,25)/t12-,13-,16+,20-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 15.2 -44.6n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191064
PNG
(US9181253, 126)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NCc3cc(F)ccc3F)nc(Cl)nc12 |r|
Show InChI InChI=1S/C18H16ClF2N5O2/c19-17-24-15(22-6-8-3-9(20)1-2-11(8)21)13-16(25-17)26(7-23-13)18-4-10(18)14(28)12(27)5-18/h1-3,7,10,12,14,27-28H,4-6H2,(H,22,24,25)/t10-,12-,14+,18-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 16.5 -44.4n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191069
PNG
(US9181253, 116)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NCCF)nc(Cl)nc12 |r|
Show InChI InChI=1S/C13H15ClFN5O2/c14-12-18-10(16-2-1-15)8-11(19-12)20(5-17-8)13-3-6(13)9(22)7(21)4-13/h5-7,9,21-22H,1-4H2,(H,16,18,19)/t6-,7-,9+,13-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 32.4 -42.7n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191066
PNG
(US9181253, 128)
Show SMILES OCc1cc(F)c(F)cc1CNc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C19H18ClF2N5O3/c20-18-25-16(23-5-8-1-11(21)12(22)2-9(8)6-28)14-17(26-18)27(7-24-14)19-3-10(19)15(30)13(29)4-19/h1-2,7,10,13,15,28-30H,3-6H2,(H,23,25,26)/t10-,13-,15+,19-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 40.4 -42.2n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191060
PNG
(US9181253, 122)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NCc3ccccc3F)nc(Cl)nc12 |r|
Show InChI InChI=1S/C18H17ClFN5O2/c19-17-23-15(21-7-9-3-1-2-4-11(9)20)13-16(24-17)25(8-22-13)18-5-10(18)14(27)12(26)6-18/h1-4,8,10,12,14,26-27H,5-7H2,(H,21,23,24)/t10-,12-,14+,18-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 41.5 -42.1n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191059
PNG
(US9181253, 121)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC(C3CC3)C3CC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C18H22ClN5O2/c19-17-22-15(21-12(8-1-2-8)9-3-4-9)13-16(23-17)24(7-20-13)18-5-10(18)14(26)11(25)6-18/h7-12,14,25-26H,1-6H2,(H,21,22,23)/t10-,11-,14+,18-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 47.9 -41.8n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191046
PNG
(US9181253, 109)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CCC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C15H18ClN5O2/c16-14-19-12(18-7-2-1-3-7)10-13(20-14)21(6-17-10)15-4-8(15)11(23)9(22)5-15/h6-9,11,22-23H,1-5H2,(H,18,19,20)/t8-,9-,11+,15-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 51.6 -41.6n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191056
PNG
(US9181253, 118)
Show SMILES CCC(CC)Nc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C16H22ClN5O2/c1-3-8(4-2)19-13-11-14(21-15(17)20-13)22(7-18-11)16-5-9(16)12(24)10(23)6-16/h7-10,12,23-24H,3-6H2,1-2H3,(H,19,20,21)/t9-,10-,12+,16-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 52 -41.6n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191057
PNG
(US9181253, 119)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NCC3CC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C15H18ClN5O2/c16-14-19-12(17-5-7-1-2-7)10-13(20-14)21(6-18-10)15-3-8(15)11(23)9(22)4-15/h6-9,11,22-23H,1-5H2,(H,17,19,20)/t8-,9-,11+,15-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 68.4 -40.9n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191055
PNG
(US9181253, 117)
Show SMILES CC(C)Nc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C14H18ClN5O2/c1-6(2)17-11-9-12(19-13(15)18-11)20(5-16-9)14-3-7(14)10(22)8(21)4-14/h5-8,10,21-22H,3-4H2,1-2H3,(H,17,18,19)/t7-,8-,10+,14-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 72.2 -40.8n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191069
PNG
(US9181253, 116)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NCCF)nc(Cl)nc12 |r|
Show InChI InChI=1S/C13H15ClFN5O2/c14-12-18-10(16-2-1-15)8-11(19-12)20(5-17-8)13-3-6(13)9(22)7(21)4-13/h5-7,9,21-22H,1-4H2,(H,16,18,19)/t6-,7-,9+,13-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 72.7 -40.7n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191056
PNG
(US9181253, 118)
Show SMILES CCC(CC)Nc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C16H22ClN5O2/c1-3-8(4-2)19-13-11-14(21-15(17)20-13)22(7-18-11)16-5-9(16)12(24)10(23)6-16/h7-10,12,23-24H,3-6H2,1-2H3,(H,19,20,21)/t9-,10-,12+,16-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 78.8 -40.5n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191053
PNG
(US9181253, 113)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CC4CCC3C4)nc(Cl)nc12 |r,TLB:13:14:18.17:20|
Show InChI InChI=1S/C18H22ClN5O2/c19-17-22-15(21-11-4-8-1-2-9(11)3-8)13-16(23-17)24(7-20-13)18-5-10(18)14(26)12(25)6-18/h7-12,14,25-26H,1-6H2,(H,21,22,23)/t8?,9?,10-,11?,12-,14+,18-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 82.6 -40.4n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191065
PNG
(US9181253, 127)
Show SMILES OCc1ccc(F)c(F)c1CNc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C19H18ClF2N5O3/c20-18-25-16(23-5-9-8(6-28)1-2-11(21)13(9)22)14-17(26-18)27(7-24-14)19-3-10(19)15(30)12(29)4-19/h1-2,7,10,12,15,28-30H,3-6H2,(H,23,25,26)/t10-,12-,15+,19-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 83.2 -40.4n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191058
PNG
(US9181253, 120c)
Show SMILES CC(Nc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2)C1CC1 |r|
Show InChI InChI=1S/C16H20ClN5O2/c1-7(8-2-3-8)19-13-11-14(21-15(17)20-13)22(6-18-11)16-4-9(16)12(24)10(23)5-16/h6-10,12,23-24H,2-5H2,1H3,(H,19,20,21)/t7?,9-,10-,12+,16-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 86.8 -40.3n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191058
PNG
(US9181253, 120c)
Show SMILES CC(Nc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2)C1CC1 |r|
Show InChI InChI=1S/C16H20ClN5O2/c1-7(8-2-3-8)19-13-11-14(21-15(17)20-13)22(6-18-11)16-4-9(16)12(24)10(23)5-16/h6-10,12,23-24H,2-5H2,1H3,(H,19,20,21)/t7?,9-,10-,12+,16-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 110 -39.7n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191063
PNG
(US9181253, 125)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NCc3cccc(OCCF)c3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C20H21ClFN5O3/c21-19-25-17(23-9-11-2-1-3-12(6-11)30-5-4-22)15-18(26-19)27(10-24-15)20-7-13(20)16(29)14(28)8-20/h1-3,6,10,13-14,16,28-29H,4-5,7-9H2,(H,23,25,26)/t13-,14-,16+,20-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 114 -39.6n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191050
PNG
(US9181253, 110)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CCCCC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C17H22ClN5O2/c18-16-21-14(20-9-4-2-1-3-5-9)12-15(22-16)23(8-19-12)17-6-10(17)13(25)11(24)7-17/h8-11,13,24-25H,1-7H2,(H,20,21,22)/t10-,11-,13+,17-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 140 -39.1n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191067
PNG
(US9181253, 107)
Show SMILES Nc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C11H12ClN5O2/c12-10-15-8(13)6-9(16-10)17(3-14-6)11-1-4(11)7(19)5(18)2-11/h3-5,7,18-19H,1-2H2,(H2,13,15,16)/t4-,5-,7+,11-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 160 -38.8n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191054
PNG
(US9181253, 114)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CC4CCC3C4)nc(Cl)nc12 |r,THB:13:14:18.17:20|
Show InChI InChI=1S/C18H22ClN5O2/c19-17-22-15(21-11-4-8-1-2-9(11)3-8)13-16(23-17)24(7-20-13)18-5-10(18)14(26)12(25)6-18/h7-12,14,25-26H,1-6H2,(H,21,22,23)/t8?,9?,10-,11?,12-,14+,18-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 200 -38.2n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191045
PNG
(US9181253, 108)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C14H16ClN5O2/c15-13-18-11(17-6-1-2-6)9-12(19-13)20(5-16-9)14-3-7(14)10(22)8(21)4-14/h5-8,10,21-22H,1-4H2,(H,17,18,19)/t7-,8-,10+,14-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 210 -38.1n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191051
PNG
(US9181253, 111)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CCCCCC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C18H24ClN5O2/c19-17-22-15(21-10-5-3-1-2-4-6-10)13-16(23-17)24(9-20-13)18-7-11(18)14(26)12(25)8-18/h9-12,14,25-26H,1-8H2,(H,21,22,23)/t11-,12-,14+,18-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 230 -37.9n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191054
PNG
(US9181253, 114)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CC4CCC3C4)nc(Cl)nc12 |r,THB:13:14:18.17:20|
Show InChI InChI=1S/C18H22ClN5O2/c19-17-22-15(21-11-4-8-1-2-9(11)3-8)13-16(23-17)24(7-20-13)18-5-10(18)14(26)12(25)6-18/h7-12,14,25-26H,1-6H2,(H,21,22,23)/t8?,9?,10-,11?,12-,14+,18-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 236 -37.8n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191053
PNG
(US9181253, 113)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CC4CCC3C4)nc(Cl)nc12 |r,TLB:13:14:18.17:20|
Show InChI InChI=1S/C18H22ClN5O2/c19-17-22-15(21-11-4-8-1-2-9(11)3-8)13-16(23-17)24(7-20-13)18-5-10(18)14(26)12(25)6-18/h7-12,14,25-26H,1-6H2,(H,21,22,23)/t8?,9?,10-,11?,12-,14+,18-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 315 -37.1n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191067
PNG
(US9181253, 107)
Show SMILES Nc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C11H12ClN5O2/c12-10-15-8(13)6-9(16-10)17(3-14-6)11-1-4(11)7(19)5(18)2-11/h3-5,7,18-19H,1-2H2,(H2,13,15,16)/t4-,5-,7+,11-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 350 -36.8n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191059
PNG
(US9181253, 121)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC(C3CC3)C3CC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C18H22ClN5O2/c19-17-22-15(21-12(8-1-2-8)9-3-4-9)13-16(23-17)24(7-20-13)18-5-10(18)14(26)11(25)6-18/h7-12,14,25-26H,1-6H2,(H,21,22,23)/t10-,11-,14+,18-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 470 -36.1n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191050
PNG
(US9181253, 110)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CCCCC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C17H22ClN5O2/c18-16-21-14(20-9-4-2-1-3-5-9)12-15(22-16)23(8-19-12)17-6-10(17)13(25)11(24)7-17/h8-11,13,24-25H,1-7H2,(H,20,21,22)/t10-,11-,13+,17-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 500 -36.0n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191051
PNG
(US9181253, 111)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CCCCCC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C18H24ClN5O2/c19-17-22-15(21-10-5-3-1-2-4-6-10)13-16(23-17)24(9-20-13)18-7-11(18)14(26)12(25)8-18/h9-12,14,25-26H,1-8H2,(H,21,22,23)/t11-,12-,14+,18-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 560 -35.7n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191052
PNG
(US9181253, 112)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CCCCCCC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C19H26ClN5O2/c20-18-23-16(22-11-6-4-2-1-3-5-7-11)14-17(24-18)25(10-21-14)19-8-12(19)15(27)13(26)9-19/h10-13,15,26-27H,1-9H2,(H,22,23,24)/t12-,13-,15+,19-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 760 -34.9n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191068
PNG
(US9181253, 115)
Show SMILES CCNc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C13H16ClN5O2/c1-2-15-10-8-11(18-12(14)17-10)19(5-16-8)13-3-6(13)9(21)7(20)4-13/h5-7,9,20-21H,2-4H2,1H3,(H,15,17,18)/t6-,7-,9+,13-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 930 -34.4n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191064
PNG
(US9181253, 126)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NCc3cc(F)ccc3F)nc(Cl)nc12 |r|
Show InChI InChI=1S/C18H16ClF2N5O2/c19-17-24-15(22-6-8-3-9(20)1-2-11(8)21)13-16(25-17)26(7-23-13)18-4-10(18)14(28)12(27)5-18/h1-3,7,10,12,14,27-28H,4-6H2,(H,22,24,25)/t10-,12-,14+,18-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 1.26E+3 -33.7n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A3 [I248L]


(Homo sapiens (Human))		BDBM191052
PNG
(US9181253, 112)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CCCCCCC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C19H26ClN5O2/c20-18-23-16(22-11-6-4-2-1-3-5-7-11)14-17(24-18)25(10-21-14)19-8-12(19)15(27)13(26)9-19/h10-13,15,26-27H,1-9H2,(H,22,23,24)/t12-,13-,15+,19-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 1.53E+3 -33.2n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191066
PNG
(US9181253, 128)
Show SMILES OCc1cc(F)c(F)cc1CNc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C19H18ClF2N5O3/c20-18-25-16(23-5-8-1-11(21)12(22)2-9(8)6-28)14-17(26-18)27(7-24-14)19-3-10(19)15(30)13(29)4-19/h1-2,7,10,13,15,28-30H,3-6H2,(H,23,25,26)/t10-,13-,15+,19-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 1.91E+3 -32.6n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A2a


(Homo sapiens (Human))		BDBM191053
PNG
(US9181253, 113)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CC4CCC3C4)nc(Cl)nc12 |r,TLB:13:14:18.17:20|
Show InChI InChI=1S/C18H22ClN5O2/c19-17-22-15(21-11-4-8-1-2-9(11)3-8)13-16(23-17)24(7-20-13)18-5-10(18)14(26)12(25)6-18/h7-12,14,25-26H,1-6H2,(H,21,22,23)/t8?,9?,10-,11?,12-,14+,18-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 2.45E+3 -32.0n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A2a


(Homo sapiens (Human))		BDBM191050
PNG
(US9181253, 110)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CCCCC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C17H22ClN5O2/c18-16-21-14(20-9-4-2-1-3-5-9)12-15(22-16)23(8-19-12)17-6-10(17)13(25)11(24)7-17/h8-11,13,24-25H,1-7H2,(H,20,21,22)/t10-,11-,13+,17-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 2.72E+3 -31.8n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A2a


(Homo sapiens (Human))		BDBM191046
PNG
(US9181253, 109)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CCC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C15H18ClN5O2/c16-14-19-12(18-7-2-1-3-7)10-13(20-14)21(6-17-10)15-4-8(15)11(23)9(22)5-15/h6-9,11,22-23H,1-5H2,(H,18,19,20)/t8-,9-,11+,15-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 3.02E+3 -31.5n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A2a


(Homo sapiens (Human))		BDBM191067
PNG
(US9181253, 107)
Show SMILES Nc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C11H12ClN5O2/c12-10-15-8(13)6-9(16-10)17(3-14-6)11-1-4(11)7(19)5(18)2-11/h3-5,7,18-19H,1-2H2,(H2,13,15,16)/t4-,5-,7+,11-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 3.14E+3 -31.4n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191063
PNG
(US9181253, 125)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NCc3cccc(OCCF)c3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C20H21ClFN5O3/c21-19-25-17(23-9-11-2-1-3-12(6-11)30-5-4-22)15-18(26-19)27(10-24-15)20-7-13(20)16(29)14(28)8-20/h1-3,6,10,13-14,16,28-29H,4-5,7-9H2,(H,23,25,26)/t13-,14-,16+,20-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 3.58E+3 -31.1n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A2a


(Homo sapiens (Human))		BDBM191045
PNG
(US9181253, 108)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C14H16ClN5O2/c15-13-18-11(17-6-1-2-6)9-12(19-13)20(5-16-9)14-3-7(14)10(22)8(21)4-14/h5-8,10,21-22H,1-4H2,(H,17,18,19)/t7-,8-,10+,14-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 3.70E+3 -31.0n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A2a


(Homo sapiens (Human))		BDBM191056
PNG
(US9181253, 118)
Show SMILES CCC(CC)Nc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C16H22ClN5O2/c1-3-8(4-2)19-13-11-14(21-15(17)20-13)22(7-18-11)16-5-9(16)12(24)10(23)6-16/h7-10,12,23-24H,3-6H2,1-2H3,(H,19,20,21)/t9-,10-,12+,16-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 3.70E+3 -31.0n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A2a


(Homo sapiens (Human))		BDBM191051
PNG
(US9181253, 111)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CCCCCC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C18H24ClN5O2/c19-17-22-15(21-10-5-3-1-2-4-6-10)13-16(23-17)24(9-20-13)18-7-11(18)14(26)12(25)8-18/h9-12,14,25-26H,1-8H2,(H,21,22,23)/t11-,12-,14+,18-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 3.93E+3 -30.9n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A2a


(Homo sapiens (Human))		BDBM191059
PNG
(US9181253, 121)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC(C3CC3)C3CC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C18H22ClN5O2/c19-17-22-15(21-12(8-1-2-8)9-3-4-9)13-16(23-17)24(7-20-13)18-5-10(18)14(26)11(25)6-18/h7-12,14,25-26H,1-6H2,(H,21,22,23)/t10-,11-,14+,18-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 3.95E+3 -30.8n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A2a


(Homo sapiens (Human))		BDBM191054
PNG
(US9181253, 114)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NC3CC4CCC3C4)nc(Cl)nc12 |r,THB:13:14:18.17:20|
Show InChI InChI=1S/C18H22ClN5O2/c19-17-22-15(21-11-4-8-1-2-9(11)3-8)13-16(23-17)24(7-20-13)18-5-10(18)14(26)12(25)6-18/h7-12,14,25-26H,1-6H2,(H,21,22,23)/t8?,9?,10-,11?,12-,14+,18-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 4.08E+3 -30.8n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A2a


(Homo sapiens (Human))		BDBM191057
PNG
(US9181253, 119)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NCC3CC3)nc(Cl)nc12 |r|
Show InChI InChI=1S/C15H18ClN5O2/c16-14-19-12(17-5-7-1-2-7)10-13(20-14)21(6-18-10)15-3-8(15)11(23)9(22)4-15/h6-9,11,22-23H,1-5H2,(H,17,19,20)/t8-,9-,11+,15-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 4.41E+3 -30.6n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A1


(Homo sapiens (Human))		BDBM191060
PNG
(US9181253, 122)
Show SMILES O[C@H]1C[C@]2(C[C@H]2[C@H]1O)n1cnc2c(NCc3ccccc3F)nc(Cl)nc12 |r|
Show InChI InChI=1S/C18H17ClFN5O2/c19-17-23-15(21-7-9-3-1-2-4-11(9)20)13-16(24-17)25(8-22-13)18-5-10(18)14(27)12(26)6-18/h1-4,8,10,12,14,26-27H,5-7H2,(H,21,23,24)/t10-,12-,14+,18-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 4.79E+3 -30.4n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
Adenosine receptor A2a


(Homo sapiens (Human))		BDBM191066
PNG
(US9181253, 128)
Show SMILES OCc1cc(F)c(F)cc1CNc1nc(Cl)nc2n(cnc12)[C@]12C[C@H]1[C@@H](O)[C@@H](O)C2 |r|
Show InChI InChI=1S/C19H18ClF2N5O3/c20-18-25-16(23-5-8-1-11(21)12(22)2-9(8)6-28)14-17(26-18)27(7-24-14)19-3-10(19)15(30)13(29)4-19/h1-2,7,10,13,15,28-30H,3-6H2,(H,23,25,26)/t10-,13-,15+,19-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
US Patent
 7.51E+3 -29.2n/an/an/an/an/a7.525



The United States of America, as represented by the Secretary, Department of Health and Human Services

US Patent


Assay Description
Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...

US Patent US9181253 (2015)


BindingDB Entry DOI: 10.7270/Q2CV4GJ4
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%